Dianthus Therapeutics (DNTH) Short-term Investments (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Short-term Investments of $353.2 million for Q4 2025, up 39.91% year-over-year from $252.4 million in Q4 2024, and up 1.9% quarter-over-quarter from $346.6 million in Q3 2025.
Dianthus Therapeutics (DNTH) Short-term Investments (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Short-term Investments history runs 9 years deep, the most recent figure standing at $353.2 million for Q4 2025.
- In Q4 2025, Short-term Investments rose 39.91% year-over-year to $353.2 million; the TTM figure through Dec 2025 stood at $353.2 million (up 39.91% YoY), while the FY2025 annual figure was $353.2 million, up 39.91% from the prior year.
- Short-term Investments for Q4 2025 stood at $353.2 million, up from $346.6 million in the prior quarter.
- The five-year high for Short-term Investments was $353.2 million in Q4 2025, with the low at $15.0 million in Q2 2023.
- The 5-year median for Short-term Investments is $64.7 million (2022), against an average of $121.2 million.
- The sharpest annual moves came in 2023 and 2024: Short-term Investments sank 82.32% in 2023, then surged 659.33% in 2024.
- Dianthus Therapeutics' Short-term Investments stood at $45.3 million in 2021, then jumped by 32.8% to $60.1 million in 2022, then tumbled by 31.16% to $41.4 million in 2023, then soared by 509.88% to $252.4 million in 2024, then soared by 39.91% to $353.2 million in 2025.
- Business Quant data shows DNTH's Short-term Investments at $353.2 million in Q4 2025, $346.6 million in Q3 2025, and $244.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 353.21 Mn |
| Sep 30, 2025 | 346.63 Mn |
| Jun 30, 2025 | 244.15 Mn |
| Mar 31, 2025 | 253.11 Mn |
| Dec 31, 2024 | 252.45 Mn |
| Sep 30, 2024 | 247.45 Mn |
| Jun 30, 2024 | 46.54 Mn |
| Mar 31, 2024 | 47.31 Mn |
| Dec 31, 2023 | 41.39 Mn |
| Sep 30, 2023 | 32.59 Mn |
| Jun 30, 2023 | 14.96 Mn |
| Mar 31, 2023 | 29.68 Mn |
| Dec 31, 2022 | 60.13 Mn |
| Sep 30, 2022 | 69.26 Mn |
| Jun 30, 2022 | 84.59 Mn |
| Mar 31, 2022 | 84.84 Mn |
| Dec 31, 2021 | 45.28 Mn |
| Sep 30, 2021 | 35.08 Mn |
| Jun 30, 2021 | 52.77 Mn |
| Mar 31, 2021 | 83.00 Mn |